About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

A New Drug That Acts on Mitochondria Proves Indispensable

by Jayashree on August 18, 2007 at 12:33 PM
Font : A-A+

A New Drug That Acts on Mitochondria Proves Indispensable

A new injection that works on the body's mitochondria, sausage-shaped "powerhouses" in the cells that turn the food eaten into energy, may one day prove to be the "elixir of life" by slowing down the ageing process, says a report.

A research has suggested that the deterioration of mitochondria is a major cause of ageing.

Advertisement

One unique feature of mitochondria is that they have their own DNA, known as mitochondrial DNA, which is inherited from the mother only. Defects in this DNA can cause genetic disease, such as diabetes, blindness and heart problems.

Since the mitochondrial DNA are also linked to ageing, the researchers believe that fixing the flaws in them can slow down the onset of old age. But gene therapy, which involves inserting healthy DNA into mitochondria, has failed to fix flaws to date.
Advertisement

Scientists at Marie Curie University in Paris have now achieved success in inserting the functional genes with an "address code" in the mitochondria, and thereby repairing the damage behind a rare form of blindness and a muscle wasting disease.

The researchers believe that the same approach may be used to create injections of genes that will erase flaws though to be linked to the ageing process. Such injections would be effective in slowing down ageing but not in halting it completely.

"It is not a panacea but, if successful, it might potentially correct part of this ageassociated damage to mitochondria which might be important in slowing down ageing," the Daily Mail quoted Professor Patrick Chinnery, a leading British expert on mitochondrial disorders, as telling New Scientist magazine.

"What they are doing sounds potentially a very clever idea. There is no treatment for these diseases, so any advance is clearly of great interest," Professor Chinnery added.

The French researchers behind the breakthrough are now planning to move their experiments from cells to rats, with human treatments being the ultimate aim.

They have to ensure that the therapy does not disrupt other vital processes, and that genes are taken to the right parts of the body without causing harmful side effects to other tissues.

Source: ANI
JAY/B
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity 

Recommended Reading
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Encyclopedia section of medindia explains in brief about Nucleoside Reverse Transcriptase ......
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use